1,314
Views
0
CrossRef citations to date
0
Altmetric
Articles

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis

, &
Pages 20-34 | Received 05 Oct 2021, Accepted 21 Dec 2021, Published online: 20 Jan 2022

References

  • Ahn, H., & Lee, G. S. (2017). Isorhamnetin and hyperoside derived from water dropwort inhibits inflammasome activation. Phytomedicine, 24, 77–86. https://doi.org/10.1016/j.phymed.2016.11.019
  • Anstee, Q. M., & Goldin, R. D. (2006). Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. International Journal of Experimental Pathology, 87(1), 1–16. https://doi.org/10.1111/j.0959-9673.2006.00465.x
  • Begriche, K., Massart, J., Robin, M. A., Bonnet, F., & Fromenty, B. (2013). Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology, 58(4), 1497–1507. https://doi.org/10.1002/hep.26226
  • Bettaieb, A., Jiang, J. X., Sasaki, Y., Chao, T. I., Kiss, Z., Chen, X., Tian, J., Katsuyama, M., Yabe-Nishimura, C., Xi, Y., Szyndralewiez, C., Schröder, K., Shah, A., Brandes, R. P., Haj, F. G., & Natalie J. T. (2015). Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastroenterology, 149(2), 468–480.e10. https://doi.org/10.1053/j.gastro.2015.04.009
  • Caballero, F., Fernandez, A., Matias, N., Martinez, L., Fucho, R., Elena, M., Caballeria, J., Morales, A., Fernandez-Checa, J. C., & Garcia-Ruiz, C. (2010). Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: Impact on mitochondrial S-adenosyl-L-methionine and glutathione. Journal of Biological Chemistry, 285(24), 18528–18536. https://doi.org/10.1074/jbc.M109.099333
  • Casoinic, F., Sampelean, D., Buzoianu, A. D., Hancu, N., & Baston, D. (2016). Serum levels of oxidative stress markers in patients with type 2 diabetes mellitus and Non-alcoholic steatohepatitis. Romanian Journal of Internal Medicine, 54(4), 228–236. https://doi.org/10.1515/rjim-2016-0035
  • Cichoz-Lach, H., & Michalak, A. (2014). Oxidative stress as a crucial factor in liver diseases. World Journal of Gastroenterology, 20(25), 8082–8091. https://doi.org/10.3748/wjg.v20.i25.8082
  • George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., & Farrell, G. (2003). Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Journal of Hepatology, 39(5), 756–764. https://doi.org/10.1016/S0168-8278(03)00376-3
  • Han, Y. Q., Huang, Z. M., Yang, X. B., Liu, H. Z., & Wu, G. X. (2008). In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. Journal of Ethnopharmacology, 118(1), 148–153. https://doi.org/10.1016/j.jep.2008.03.024
  • Harrison-Findik, D. D., & Lu, S. (2015). The effect of alcohol and hydrogen peroxide on liver hepcidin gene expression in mice lacking antioxidant enzymes, glutathione peroxidase-1 or catalase. Biomolecules, 5(2), 793–807. https://doi.org/10.3390/biom5020793
  • Hatting, M., Zhao, G., Schumacher, F., Sellge, G., Al Masaoudi, M., Gabetaler, N., Boekschoten, M., Muller, M., Liedtke, C., Cubero, F. J., & Trautwein C. (2013). Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents. Hepatology, 57(6), 2189–2201. https://doi.org/10.1002/hep.26271
  • Heidelbaugh, J. J., & Sherbondy, M. (2006). Cirrhosis and chronic liver failure: Part II. Complications and Treatment. American Academy of Family Physicians, 74(5), 767–776.
  • Hwang, C. R., Hwang, I. G., Kim, H. Y., Kang, T. S., Kim, Y. B., Joo, S. S., Lee, I. S., & Jeong, H. S. (2011). Antioxidant component and activity of dropwort (Oenanthe javanica) ethanol extracts. Journal of the Korean Society of Food Science and Nutrition, 40(2), 316–320. https://doi.org/10.3746/jkfn.2011.40.2.316
  • Jadeja, R., Devkar, R. V., & Nammi, S. (2014). Herbal medicines for the treatment of nonalcoholic steatohepatitis: Current scenario and future prospects. Evidence-Based Complementary and Alternative Medicine, 2014, 1–18. https://doi.org/10.1155/2014/648308
  • Jorgacevic, B., Mladenovic, D., Ninkovic, M., Prokic, V., Stankovic, M. N., Aleksic, V., Cerovic, I., Vukicevic, R. J., Vucevic, D., Stankovic, M., & Radosavljević T. (2014). Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. Human & Experimental Toxicology, 33(7), 701–709. https://doi.org/10.1177/0960327113506723
  • Kim, D. W., Cho, H. I., Kim, K. M., Kim, S. J., Choi, J. S., Kim, Y. S., & Lee, S. M. (2012). Isorhamnetin-3-O-galactoside protects against CCl4-induced hepatic injury in mice. Biomolecules & Therapeutics (Seoul), 20(4), 406–412. https://doi.org/10.4062/biomolther.2012.20.4.406
  • Kim, J. Y., Kim, K. H., Lee, Y. J., Lee, S. H., Park, J. C., & Nam, D. H. (2009). Oenanthe javanica extract accelerates ethanol metabolism in ethanol-treated animals. BMB Reports, 42(8), 482–485. https://doi.org/10.5483/BMBRep.2009.42.8.482
  • Kim, S. B., Kang, O. H., Lee, Y. S., Han, S. H., Ahn, Y. S., Cha, S. W., Seo, Y. S., Kong, R., & Kwon, D. Y. (2016). Hepatoprotective effect and synergism of bisdemethoycurcumin against MCD diet-induced nonalcoholic fatty liver disease in mice. PLoS One, 11(2), e0147745.
  • Kim, T. H., Ku, S. K., & Bae, J. S. (2013). Anti-inflammatory activities of isorhamnetin-3-O-galactoside against HMGB1-induced inflammatory responses in both HUVECs and CLP-induced septic mice. Journal of Cellular Biochemistry, 114(2), 336–345. https://doi.org/10.1002/jcb.24361
  • Lee, D. H., Lee, J. S., Lee, I. H., & Hong, J. T. (2020). Therapeutic potency of fermented field water-dropwort (Oenanthe javanica (Blume) DC.) in ethanol-induced liver injury. RSC Advances, 10(3), 1544–1551. https://doi.org/10.1039/C9RA08976D
  • Matsunaga, Y., Nakatsu, Y., Fukushima, T., Okubo, H., Iwashita, M., Sakoda, H., Fujishiro, M., Yamamotoya, T., Kushiyama, A., Takahashi, S., Tsuchiya, Y., Kamata, H., Tokunaga, F., Iwai, K., & Asano, T. (2015). LUBAC formation Is impaired in the livers of mice with MCD-dependent nonalcoholic steatohepatitis. Mediators of Inflammation, 2015, 1–10. https://doi.org/10.1155/2015/125380
  • Matteoni, C. A., Younossi, Z. M., Gramlich, T., Boparai, N., Liu, Y. C., & McCullough, A. J. (1999). Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology, 116(6), 1413–1419. https://doi.org/10.1016/S0016-5085(99)70506-8
  • Ore, A., & Akinloye, O. A. (2019). Oxidative stress and antioxidant biomarkers in clinical and experimental models of Non-alcoholic fatty liver disease. Medicina (Kaunas), 55(2). https://doi.org/10.3390/medicina55020026
  • Osna, N. A., Donohue, T. M., Jr., & Kharbanda, K. K. (2017). Alcoholic liver disease: Pathogenesis and current management. Alcohol Research: Current Reviews, 38(2), 147–161.
  • Park, J. C., Yu, Y. B., Lee, J. H., Hattori, M., Lee, C. K., & Choi, J. W. (1996). Protective effect of Oenanthe javanica on the hepatic lipid peroxidation in bromobenzene-treated rats and its bioactive component. Planta Medica, 62(6), 488–490. https://doi.org/10.1055/s-2006-957954
  • Popescu, M., Popescu, I. A., Stanciu, M., Cazacu, S. M., Ianosi, N. G., Comanescu, M. V., Singer, C. E., & Neagoe, C. D. (2016). Non-alcoholic fatty liver disease - clinical and histopathological aspects. Romanian Journal of Morphology and Embryology, 57(4), 1295–1302.
  • Seki, S., Kitada, T., Yamada, T., Sakaguchi, H., Nakatani, K., & Wakasa, K. (2002). In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. Journal of Hepatology, 37(1), 56–62. https://doi.org/10.1016/S0168-8278(02)00073-9
  • Severgnini, M., Sherman, J., Sehgal, A., Jayaprakash, N. K., Aubin, J., Wang, G., Zhang, L., Peng, C. G., Yucius, K., Butler, J., & Fitzgerald K. (2012). A rapid two-step method for isolation of functional primary mouse hepatocytes: Cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology, 64(2), 187–195. https://doi.org/10.1007/s10616-011-9407-0
  • Soret, P. A., Magusto J., Housset C., & Gautheron J. 2020 In vitro and In vivo models of non-alcoholic fatty liver disease: A critical appraisal. Journal of Clinical Medicine. 10(1), 36. https://doi.org/10.3390/jcm10010036
  • Stephenson, K., Kennedy, L., Hargrove, L., Demieville, J., Thomson, J., Alpini, G., & Francis, H. (2018). Updates on dietary models of nonalcoholic fatty liver disease: Current studies and insights. Gene Expression Patterns, 18(1), 5–17. https://doi.org/10.3727/105221617X15093707969658
  • Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014). Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology, 59(3), 886–897. https://doi.org/10.1002/hep.26749
  • Tacke, F., & Zimmermann, H. W. (2014). Macrophage heterogeneity in liver injury and fibrosis. Journal of Hepatology, 60(5), 1090–1096. https://doi.org/10.1016/j.jhep.2013.12.025
  • Tarantino, G., Savastano, S., & Colao, A. (2010). Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World Journal of Gastroenterology, 16(38), 4773–4783. https://doi.org/10.3748/wjg.v16.i38.4773
  • Tilg, H., & Moschen, A. R. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology, 52(5), 1836–1846. https://doi.org/10.1002/hep.24001
  • Tosello-Trampont, A. C., Landes, S. G., Nguyen, V., Novobrantseva, T. I., & Hahn, Y. S. (2012). Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. Journal of Biological Chemistry, 287(48), 40161–40172. https://doi.org/10.1074/jbc.M112.417014
  • van der Vliet, A., Janssen-Heininger Y. M. 2014 Hydrogen peroxide as a damage signal in tissue injury and inflammation: Murderer, mediator, or messenger? Journal of Cellular Biochemistry. 115(3):427-435. https://doi.org/10.1002/jcb.24683
  • Varela-Rey, M., Embade, N., Ariz, U., Lu, S. C., Mato, J. M., & Martinez-Chantar, M. L. (2009). Non-alcoholic steatohepatitis and animal models: Understanding the human disease. International Journal of Biochemistry and Cell Biology, 41(5), 969–976. https://doi.org/10.1016/j.biocel.2008.10.027
  • Vernon, G., Baranova, A., & Younossi, Z. M. (2011). Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics, 34(3), 274–285. https://doi.org/10.1111/j.1365-2036.2011.04724.x
  • Wang, X., Hausding, M., Weng, S. Y., Kim, Y. O., Steven, S., Klein, T., Daiber, A., & Schuppan, D. (2018). Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis. Antioxidants & Redox Signaling, 28(2), 87–109. https://doi.org/10.1089/ars.2016.6953
  • Wang, Y., Li, J., Zhuge, L., Su, D., Yang, M., Tao, S., & Li, J. (2014). Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. Experimental and Therapeutic Medicine, 7(3), 663–668. https://doi.org/10.3892/etm.2013.1461
  • Wehr, A., Baeck, C., Ulmer, F., Gassler, N., Hittatiya, K., Luedde, T., Neumann, U. P., Trautwein, C., Tacke, F., & Alisi A. (2014). Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. PLoS One, 9(11), e112327. https://doi.org/10.1371/journal.pone.0112327
  • Yang, J. H., Kim, S. C., Shin, B. Y., Jin, S. H., Jo, M. J., Jegal, K. H., Kim, Y. W., Lee, J. R., Ku, S. K., Cho, I. J., & Ki, S. H. (2013). O-Methylated flavonol isorhamnetin prevents acute inflammation through blocking of NF-kappaB activation. Food and Chemical Toxicology, 59, 362–372. https://doi.org/10.1016/j.fct.2013.05.049
  • Yang, S. A., Jung, Y. S., Lee, S. J., Park, S. C., Kim, M. J., Lee, E. J., Byun, H. J., Jhee, K. H., & Lee, S. P. (2014). Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 67, 154–160. https://doi.org/10.1016/j.fct.2014.02.010
  • Zhang, X., Han, J., Man, K., Li, X., Du, J., Chu, E. S., Go, M. Y., Sung, J. J., & Yu, J. (2016). CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. Journal of Hepatology, 64(1), 160–170. https://doi.org/10.1016/j.jhep.2015.09.005